Drugs / Cethromycin
Cethromycin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00336544 | Jun 2006 → May 2007 | pneumonia | Advanced Life Sciences, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00336505 | Dec 2005 → Oct 2007 | pneumonia | Advanced Life Sciences, Inc. | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cethromycin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00336505 ↗ |
| Known as | A-195773 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989904 ↗ |
| Known as | ABBOTT-195773 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989904 ↗ |
| Known as | ABT-773 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989904 ↗ |
| Known as | Cethromycine | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989904 ↗ |
| Known as | Cetromicina | ChEMBL registry synonym — accepted as the source's own label CHEMBL3989904 ↗ |
| Modality | Small molecule | “a new ketolide, cethromycin.” NCT00336505 ↗ |
| Route | Oral | “administered orally” NCT00336505 ↗ |